# Trending Content OS — Daily Run
**Run date:** 2026-10-28

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  active_tools: [serpapi_news, serpapi_trends, competitor_list_fallback]
  inactive_tools: [reddit_live, exa_search, social_x_search, content_database]
  can_run_signal_listener: true
  notes: "site_url not configured — self-check skipped; competitor-list fallback (configs/competitor_list.yaml) used qualitatively for SERP-saturation judgment. Reddit/Exa/X not independently queried this run; Google Trends + Google News Radar prefetch used as primary live signal."
next_action: run_signal_listener
```

---

## 2. Google News Radar Coverage Summary (144 unique headlines, 12 queries)

| Cluster | Disposition | Why |
|---|---|---|
| **Ebola / DRC + Nigeria escalation** — [Al Jazeera](https://www.aljazeera.com/news/2026/10/24/who-announces-start-of-ebola-vaccine-clinical-trial-in-dr-congo), CNN (Nigeria case) | **Retained — update (P1)** | New development: first confirmed case outside DRC, evacuated to Switzerland. Google Trends breakout term "nigeria" confirms real-time search demand. |
| **CDC antibiotic-resistance / "superbug" report** — Washington Post (via Trends) | **Retained — new (P1)** | Breakout Trends term "drug resistance" + tier-1 institutional source (CDC). |
| **GLP-1/retatrutide vs. Ozempic trial data** — ABC News (via Trends) | **Retained — new (P2)** | Breakout Trends term; drug/treatment claim routed through 02b. |
| **WHO Lancet Countdown climate-health report** — [WHO](https://www.who.int/news/item/28-10-2026-climate-change-is-a-growing-health-emergency--lancet-countdown-warns) | **Retained — new (P2)** | Fresh (10/28) institutional report, undercovered in our radar pull. |
| **FDA recall cluster**: toothpaste, butter, sprats, fruit cocktail, pet food | **Mixed** | Toothpaste = existing (10/23). Butter ([The Hill](https://thehill.com/homenews/state-watch/6175447-miyokos-creamery-butter-recalled/), [The Healthy](https://www.thehealthy.com/news/butter-recall-october-2026/)) = **retained, update (P3)**. Fruit cocktail = **rejected** (single-source, no corroboration). Sprats = **rejected** (narrow distribution). Darwin's pet food = **rejected** (excluded category). |
| **Health care costs / medical debt** — [NYT](https://www.nytimes.com/2026/10/22/business/health-insurance-costs-workers-premiums-deductibles.html), [NPR](https://www.npr.org/2026/10/22/nx-s1-6008153/health-insurance-costs-kff-commonwealth), [KFF](https://www.kff.org/health-costs/americans-challenges-with-health-care-costs/) | **Rejected — existing** | Same KFF/Commonwealth Fund convergence covered 10/27; no new data point. |
| **Clinical-trial access/business** (Walmart/Care Access, Ochsner-Paradigm, Cleveland Clinic AI award, UK trial speed, BMS partnership) | **Rejected** | Pharma/retail business news, no direct patient-facing health angle. |
| **Medical-study cluster** (Stanford preterm, Yale amino acid, OU weight-loss surgery, NIH T-cell, Mayo KRAS vaccine, PTSD trial) | **Rejected — existing** | All covered 10/24–10/27, no new development. |
| **Beer/wine/spirits mortality study** — [News-Medical](https://www.news-medical.net/news/20261025/Beer-wine-or-spirits-A-large-study-finds-different-mortality-patterns-for-each.aspx) | **Monitor (02b)** | Non-trusted-tier secondary source; journal/DOI not identified. |
| **HIV newborn dosing trial** — [News-Medical](https://www.news-medical.net/news/20261022/Clinical-trial-establishes-effective-HIV-dosing-regimen-for-full-term-newborns.aspx) | **Monitor** | Narrow audience; deferred for a future angle. |
| **Wellness lifestyle/campus cluster** (darties, campus fairs, gym expansions, mahjong travel) | **Rejected** | Off-category / local interest / no evidence angle. |
| **Calley Means wellness-company stake** — NYT | **Rejected** | Political/conflict-of-interest business story, excluded category. |
| **UNM HSC cybersecurity event** | **Rejected** | Excluded category (local hospital/IT news). |
| **Anthropic/Claude drug-development research** | **Rejected** | Off-category (tech/business, no consumer health angle). |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-10-28T13:00:00Z"
  total_signals_reviewed: 144  # Google News Radar + 9 Google Trends keyword blocks + Trending Now
  total_signals_retained: 5
  total_rejected: ~24 (itemized below) + 2 routed to Monitor via 02b
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 7
    brand_safety: 1
    duplicate: 9
    weak_signal: 5
    unverified_claim: 2
    other: 0
  highest_priority_topic: "CDC antibiotic-resistance 'superbug' threat report"
  strongest_signal_source: "CDC.gov / Washington Post (tier-1 convergence) + Google Trends breakout"
  tools_unavailable: [reddit_live, exa_search, social_x_search, content_database]
  notes: >
    Ebola is a 3rd-consecutive-day recurring theme (10/25 vaccine trial, 10/27 case-count milestone,
    today's Nigeria escalation) — flagged per recurrence rule but retained as update given genuine
    new development (cross-border spread). Health-care-cost cluster also recurring but with
    no new development — rejected as existing. site_url absent; competitor-list fallback used
    for SERP-saturation calls (e.g., GLP-1/weight-loss content judged highly saturated based on
    known competitor coverage intensity in configs/competitor_list.yaml, not live scrape).
```

---

## 4. Skill 02b — Health Claim Verification Gate Routing Summary

| Topic | Risk type | Gate result | Primary source | Notes |
|---|---|---|---|---|
| Retatrutide vs. Ozempic trial | drug_or_treatment_claim | **Pass** (confidence cap: medium) | manufacturer_statement (Eli Lilly) | Company topline data, not yet peer-reviewed — flag in brief. |
| WHO Lancet Countdown report | medical_study (institutional) | **Pass** | who.int notice + Lancet Countdown (journal-affiliated) | Two converging tier-1 channels. |
| Miyoko's Creamery butter recall | recall | **Pass** (breaking-recall exception, confidence cap: medium) | trusted_secondary (The Hill + The Healthy) | FDA.gov notice not directly retrieved — verify before publish. |
| Walmart Great Value fruit cocktail recall | recall | **Reject** | none | Single source (Detroit Free Press); fails 3+-source breaking-recall exception. |
| Beer/wine/spirits mortality study | study_or_research | **Monitor** | none confirmed | News-Medical not in trusted tier; journal/DOI not identified in available coverage. |
| HIV newborn dosing clinical trial | clinical_trial | **Monitor** | — | Not rejected on verification grounds; deferred for audience/priority reasons, not scored. |

Ebola (breaking outbreak news) and CDC superbug report (data release/advisory) did not trigger 02b — neither is a specific drug/treatment/supplement/dosage/study claim requiring primary-source gating; both proceeded through standard Source Validator instead.

---

## 5. Final Editorial Priority Board

| Priority | Topic | Publish Timing | Trend | Opp. | Discover | Urgency | Confidence | Key Source |
|---|---|---|---|---|---|---|---|---|
| **P1** | Ebola spreads beyond DRC — case in Nigeria evacuated to Switzerland | immediate | 82 | 78 | 5 | now | medium | CNN [unverified URL]; [Al Jazeera](https://www.aljazeera.com/news/2026/10/24/who-announces-start-of-ebola-vaccine-clinical-trial-in-dr-congo) |
| **P1** | CDC names biggest antibiotic-resistant "superbug" threats | immediate | 80 | 74 | 5 | today | high | CDC.gov [unverified URL]; Washington Post [unverified URL] |
| **P2** | Lilly's retatrutide shows double Ozempic's weight loss, improves A1c | short_term | 73 | 68 | 4 | today | medium | ABC News [unverified URL]; Lilly statement |
| **P2** | WHO/Lancet Countdown: climate change is a growing health emergency | short_term | 62 | 65 | 4 | this_week | medium | [WHO](https://www.who.int/news/item/28-10-2026-climate-change-is-a-growing-health-emergency--lancet-countdown-warns) |
| **P3** | FDA escalates risk warning on recalled Miyoko's Creamery butter | scheduled | 58 | 62 | 4 | today | medium | [The Hill](https://thehill.com/homenews/state-watch/6175447-miyokos-creamery-butter-recalled/); [The Healthy](https://www.thehealthy.com/news/butter-recall-october-2026/) |

**Summary:** 5 topics retained, 2 P1 (immediate), 2 P2 (short_term), 1 P3 (scheduled). Immediate actions: publish Ebola escalation and CDC superbug explainer today; verify Lilly data and FDA butter notice before copy goes final.

---

## 6. Editorial Briefs

### P1 — Ebola spreads beyond DRC — first case evacuated to Switzerland

```yaml
brief:
  primary_headline: "Ebola Outbreak Spreads Beyond DRC: First Confirmed Case in Nigeria Evacuated to Switzerland"
  alternate_headlines:
    - "What the First Ebola Case Outside DRC Means for the 2026 Outbreak"
    - "Ebola Crosses Borders: Nigeria Case, Switzerland Evacuation Explained"
    - "Is Ebola Spreading? What to Know About the Nigeria Case"
  topic: "Ebola outbreak spreads beyond DRC — first confirmed case in Nigeria evacuated to Switzerland"
  primary_entity: "2026 DRC Ebola outbreak"
  search_intent: "informational + skeptical (is this spreading? am I at risk?)"
  angle: "Explain what cross-border spread actually means epidemiologically — contained medical evacuation vs. uncontrolled transmission — against the backdrop of the outbreak surpassing 10,000 cases and an active WHO vaccine trial."
  why_now: "Breakout Google Trends term 'nigeria' tied directly to this story; outbreak has been escalating for 3+ consecutive days (case-count milestone → vaccine trial start → first cross-border case)."
  integrity_flags:
    - "⚠️ Integrity note: Confirm current case counts and Nigeria evacuation details directly via WHO Disease Outbreak News before publishing; CNN was the only named source identified for the Nigeria development in this pull."
    - "⚠️ Integrity note: Distinguish a medically-evacuated, isolated case from community transmission — do not imply uncontrolled spread."
  outline:
    intro: "What happened: first confirmed case outside DRC, evacuated for treatment"
    sections:
      - "Outbreak context: case counts, affected regions"
      - "What medical evacuation means vs. community spread"
      - "Status of WHO's Ebola vaccine trial in DRC"
      - "US/global risk assessment — what health agencies are saying"
    conclusion: "What to watch next: WHO guidance, containment measures"
  key_data_points:
    - "Outbreak surpassed 10,000 cases as of 10/27 reporting"
    - "WHO Ebola vaccine clinical trial began in DRC 10/24"
    - "First case confirmed outside DRC, evacuated to Switzerland"
  source_plan:
    - { publisher: "CNN", url: "[URL unverified]", tier: 2, used_for: "Nigeria case / Switzerland evacuation" }
    - { publisher: "Al Jazeera", url: "https://www.aljazeera.com/news/2026/10/24/who-announces-start-of-ebola-vaccine-clinical-trial-in-dr-congo", tier: 2, used_for: "Vaccine trial context" }
    - { publisher: "WHO Disease Outbreak News", url: "[URL unverified — verify at who.int before publish]", tier: 1, used_for: "Official case data" }
  evidence_requirements: "Heavy — outbreak case data must be sourced to WHO/CDC directly, not secondary aggregation."
  expert_sources:
    - { type: "Infectious disease epidemiologist", name: "cite WHO/CDC spokesperson quote from existing coverage", reason: "Authoritative risk framing" }
  internal_links: ["infectious disease cluster", "WHO vaccine trial coverage"]
  visual_brief: "Map graphic: DRC outbreak zone + Nigeria case location; avoid alarmist imagery."
  seo:
    primary_keyword: "ebola nigeria case"
    supporting_keywords: ["ebola outbreak 2026", "ebola vaccine trial drc", "is ebola spreading"]
    format: "news explainer, 700-900 words"
    schema_markup: "NewsArticle"
    cluster: "infectious disease / outbreak tracking"
  discover_notes: "High AI-citation potential — specific named entities, durable Q&A format ('is Ebola spreading to other countries'), primary WHO source available."
  key_takeaways:
    - "One evacuated case ≠ uncontrolled spread — medical evacuation is a containment measure"
    - "Outbreak context: 10,000+ cases, active vaccine trial underway"
  estimated_word_count: "700-900"
execution_notes: "Verify WHO official case data and Nigeria case details before publishing — CNN is currently the sole named source for this specific development."
confidence: medium
```

---

### P1 — CDC names biggest antibiotic-resistant "superbug" threats

```yaml
brief:
  primary_headline: "CDC: These Are the Biggest Antibiotic-Resistant 'Superbug' Threats to Americans"
  alternate_headlines:
    - "What Are the Most Dangerous Drug-Resistant Infections Right Now? CDC Explains"
    - "Superbugs 101: What CDC's Latest Threat Report Means for You"
    - "Antibiotic Resistance Is Rising — Here's What the CDC Wants You to Know"
  topic: "CDC flags top antibiotic-resistant 'superbug' threats"
  primary_entity: "CDC Antibiotic Resistance Threats"
  search_intent: "informational + evaluative (how worried should I be?)"
  angle: "Translate CDC's threat classifications into a clear risk hierarchy for a general audience — what's urgent vs. serious vs. concerning, and what drives resistance in the first place."
  why_now: "Breakout Google Trends term 'drug resistance' tied directly to Washington Post coverage of CDC's report."
  integrity_flags:
    - "⚠️ Integrity note: Avoid sensationalizing 'superbug' framing beyond CDC's own threat-tier classifications; preserve CDC's urgent/serious/concerning distinctions rather than flattening into generic fear language."
  outline:
    intro: "CDC's latest antibiotic-resistance threat assessment, explained"
    sections:
      - "What counts as a 'superbug' — CDC's threat tiers"
      - "Top named threats and what makes them dangerous"
      - "Why antibiotic resistance is rising"
      - "What's being done — stewardship programs, new drug pipeline"
    conclusion: "Practical takeaways: antibiotic use, when to ask questions at the doctor's office"
  key_data_points:
    - "CDC threat-tier classification system (urgent/serious/concerning)"
    - "Specific pathogens named in CDC's latest report [verify exact list at cdc.gov before publishing]"
  source_plan:
    - { publisher: "CDC.gov", url: "[URL unverified — verify CDC AR Threats Report page before publish]", tier: 1, used_for: "Primary threat data" }
    - { publisher: "Washington Post Health", url: "[URL unverified]", tier: 1, used_for: "Report framing / context" }
  evidence_requirements: "Heavy — must cite CDC's own report directly, not just secondary coverage."
  expert_sources:
    - { type: "Infectious disease epidemiologist / CDC spokesperson", name: "cite from CDC report or WaPo coverage", reason: "Authoritative risk context" }
  internal_links: ["infectious disease cluster", "public health advisories"]
  visual_brief: "Clean infographic of CDC threat tiers; avoid stock images of bacteria in alarming red tones."
  seo:
    primary_keyword: "cdc superbug threats"
    supporting_keywords: ["antibiotic resistance 2026", "drug resistant infections", "cdc drug resistance report"]
    format: "explainer, 800-1000 words"
    schema_markup: "NewsArticle"
    cluster: "infectious disease / public health"
  discover_notes: "Strong AI-citation candidate — named institutional entity (CDC), clear Q&A fit, primary source available once confirmed."
  key_takeaways:
    - "CDC uses tiered threat levels, not a single 'superbug' label"
    - "Antibiotic stewardship (appropriate prescribing) is the main lever against resistance"
  estimated_word_count: "800-1000"
execution_notes: "Confirm exact CDC report URL and named pathogens before publishing — not directly retrieved in this pull."
confidence: high
```

---

### P2 — Retatrutide shows double Ozempic's weight loss, improves A1c

```yaml
brief:
  primary_headline: "Lilly's Retatrutide Shows Double the Weight Loss of Ozempic in New Trial Data"
  alternate_headlines:
    - "Retatrutide vs. Ozempic: What the New A1c and Weight-Loss Data Actually Show"
    - "A New GLP-1 Rival? What to Know About Retatrutide's Latest Trial Results"
  topic: "Retatrutide vs. Ozempic — new trial data on weight loss and A1c"
  primary_entity: "Retatrutide (Eli Lilly)"
  search_intent: "comparative + evaluative"
  angle: "Frame this explicitly as Lilly-reported topline trial data — not yet independently peer-reviewed — and clarify what 'double the weight loss' actually measures (vs. Ozempic specifically, not all GLP-1s)."
  why_now: "Breakout Google Trends term 'ozempic versus retatrutide a1c study' tied to ABC News coverage of Lilly's announcement."
  integrity_flags:
    - "⚠️ Integrity note: This is company-reported topline data from Eli Lilly, not yet independently peer-reviewed or published in a journal — present as 'Lilly-reported' findings, not confirmed comparative efficacy."
    - "⚠️ Integrity note: Distinguish weight-loss topline results from A1c (blood sugar) findings — they are separate endpoints."
  outline:
    intro: "What Lilly announced and why it's getting attention"
    sections:
      - "What is retatrutide — mechanism vs. Ozempic (GLP-1 only vs. triple agonist)"
      - "What the trial data actually claims (weight loss + A1c)"
      - "Caveats: company-reported, not yet peer-reviewed"
      - "What this means for current GLP-1 users"
    conclusion: "What to watch: FDA review timeline, independent publication"
  key_data_points:
    - "Lilly says retatrutide trial shows ~2x weight loss vs. Ozempic [verify exact % at primary release]"
    - "A1c improvement reported alongside weight-loss data"
  source_plan:
    - { publisher: "ABC News", url: "[URL unverified]", tier: 2, used_for: "Trial data reporting" }
    - { publisher: "Eli Lilly (manufacturer statement)", url: "[URL unverified — verify at lilly.com/news before publish]", tier: 2, used_for: "Primary claim source" }
  evidence_requirements: "Moderate-heavy — must flag single-source/company-reported status prominently."
  expert_sources:
    - { type: "Endocrinologist or obesity medicine physician", name: "TBD — cite independent commentary if available", reason: "Independent perspective on unpublished company data" }
  internal_links: ["GLP-1 / weight-loss drug cluster", "weight-loss surgery coverage"]
  visual_brief: "Simple comparison chart (retatrutide vs. Ozempic mechanism); avoid injectable-pen stock photography that implies endorsement."
  seo:
    primary_keyword: "retatrutide vs ozempic"
    supporting_keywords: ["retatrutide weight loss trial", "new weight loss drug 2026", "retatrutide a1c"]
    format: "comparative explainer, 900-1100 words"
    schema_markup: "NewsArticle"
    cluster: "GLP-1 / weight-loss drug coverage"
  discover_notes: "Good candidate — named drug entities, natural comparative query format; capped by lack of independent/peer-reviewed source."
  key_takeaways:
    - "Retatrutide is a triple-hormone agonist, mechanistically different from Ozempic"
    - "Current data is company-reported — independent confirmation still pending"
  estimated_word_count: "900-1100"
execution_notes: "SERP likely saturated (GLP-1 content is heavily covered); differentiation must come from the overstatement caveat other outlets may skip."
confidence: medium
```

---

### P2 — WHO/Lancet Countdown: climate change is a growing health emergency

```yaml
brief:
  primary_headline: "WHO: Climate Change Is Now a 'Growing Health Emergency,' Lancet Countdown Warns"
  alternate_headlines:
    - "What the 2026 Lancet Countdown Report Says About Climate and Your Health"
    - "Climate Change Is Already Affecting Public Health — Here's the Evidence"
  topic: "WHO/Lancet Countdown climate-health emergency report"
  primary_entity: "Lancet Countdown on Health and Climate Change"
  search_intent: "informational"
  angle: "Translate the report's headline indicators into concrete, individual health risk categories (heat, infectious disease shifts, air quality) rather than abstract climate policy framing."
  why_now: "Freshly published (10/28); WHO is amplifying the annual Lancet Countdown report release."
  integrity_flags:
    - "⚠️ Integrity note: Distinguish correlational climate-health risk projections from direct causal claims; cite the report's own indicators rather than extrapolating beyond its scope."
  outline:
    intro: "What the Lancet Countdown found this year"
    sections:
      - "Key health indicators tracked (heat mortality, vector-borne disease, food security)"
      - "What's new/worse in the 2026 edition"
      - "WHO's framing: why this is now an 'emergency'"
      - "What public health systems are doing in response"
    conclusion: "What individuals can realistically do / watch for"
  key_data_points:
    - "WHO statement framing climate change as a 'growing health emergency' [verify specific report indicators at who.int]"
  source_plan:
    - { publisher: "WHO", url: "https://www.who.int/news/item/28-10-2026-climate-change-is-a-growing-health-emergency--lancet-countdown-warns", tier: 1, used_for: "Primary report summary" }
  evidence_requirements: "Moderate — institutional report, cite directly, avoid overclaiming beyond stated indicators."
  expert_sources:
    - { type: "Public health / environmental health researcher", name: "cite Lancet Countdown co-author if named in full report", reason: "Credibility on climate-health linkage" }
  internal_links: ["environmental health cluster", "public health and epidemiology"]
  visual_brief: "Data-driven infographic style, not disaster imagery."
  seo:
    primary_keyword: "lancet countdown climate health report 2026"
    supporting_keywords: ["climate change health emergency who", "climate change public health risks"]
    format: "explainer, 800-1000 words"
    schema_markup: "NewsArticle"
    cluster: "environmental health"
  discover_notes: "Good candidate — named report/institution, durable topic, primary source confirmed."
  key_takeaways:
    - "WHO frames 2026 findings as an escalation, not a new discovery"
    - "Health risks span heat, infectious disease, and food security — not just one category"
  estimated_word_count: "800-1000"
execution_notes: "Only one source captured in this radar pull despite being a major annual report — expect broader Reuters/Guardian coverage to confirm; verify before publishing."
confidence: medium
```

---

### P3 — FDA escalates risk warning on recalled Miyoko's Creamery butter (concise)

```yaml
brief:
  headline: "FDA Escalates Risk Warning for Recalled Miyoko's Creamery Butter Sold in 10 States"
  topic: "FDA risk-warning escalation on recalled Miyoko's Creamery butter"
  angle: "Clarify this is an escalation/update to an already-known recall (same company's cheese recall covered 10/26) rather than a brand-new incident — help readers understand what changed."
  key_data_points:
    - "Butter sold in 10 states received an elevated FDA risk classification [verify Class level at fda.gov]"
    - "Related to Miyoko's Creamery, same company behind the 10/26 cheese recall"
  integrity_flags:
    - "⚠️ Integrity note: Official FDA.gov recall notice not directly retrieved in this pull; confirm exact risk classification and affected lot codes/states before publishing."
  expert_type_needed: "None required — regulatory/consumer-safety explainer, cite FDA directly."
  seo:
    primary_keyword: "miyoko's creamery butter recall"
    format: "news update, 400-600 words"
    serp_difficulty: "Easy"
  sources:
    - { publisher: "The Hill", url: "https://thehill.com/homenews/state-watch/6175447-miyokos-creamery-butter-recalled/" }
    - { publisher: "The Healthy (Reader's Digest)", url: "https://www.thehealthy.com/news/butter-recall-october-2026/" }
  estimated_word_count: "400-600"
```

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| Health care costs / medical debt (KFF/Commonwealth Fund/NYT/NPR) | Existing — covered 10/27, no new development |
| Toothpaste recall (Brush Buddies) | Existing — covered 10/23 |
| San Luis Obispo E. coli outbreak (local farm) | Weak signal — county-level scope, insufficient national relevance |
| Walmart Great Value fruit cocktail recall | Unverifiable (02b) — single source, fails 3+-source breaking-recall exception |
| FDA sprats advisory (Haifa Smoked Fish) | Weak signal — narrow product distribution |
| Darwin's pet food recall refusal | Off-category — excluded (pet health, no zoonotic/One Health angle) |
| Beer/wine/spirits mortality study | Monitor (02b) — non-trusted-tier secondary source, journal/DOI not identified |
| CIDRAP vaccine-communication study | Weak signal — thin/adjacent to 10/26 vaccine-trust coverage |
| VCU NIH heart-failure grant | Weak signal — pre-result funding announcement, not a finding |
| HIV newborn dosing clinical trial | Monitor — narrow audience, deferred |
| Walmart/Care Access clinical trial centers (+ Ochsner, Cleveland Clinic, UK trial speed, BMS) | Off-category — pharma/retail business news, no direct patient angle |
| Anthropic/Claude drug-development research | Off-category — tech/business |
| Nature "no direct benefit" clinical research ethics piece | Off-category — too academic/niche |
| Calley Means wellness-company stake (NYT) | Brand safety — political/conflict-of-interest |
| UNM HSC cybersecurity event | Off-category — local hospital/IT news |
| Wellness lifestyle/campus cluster (darties, fairs, gym expansions, mahjong, theater sale) | Off-category / local interest, no evidence angle |
| Gut-healthy drinks listicle (Health.com) | Weak opportunity — saturated evergreen genre, no differentiation |
| Stanford preterm labor, Yale amino acid, OU weight-loss surgery, NIH T-cell therapy, Mayo KRAS vaccine, PTSD trial | Existing — all covered 10/24–10/27 |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ **Ebola/Nigeria**: Confirm case data and evacuation details via WHO directly; CNN is sole named source for the Nigeria development.
- ⚠️ **CDC superbugs**: Preserve CDC's own threat-tier language; avoid blanket "superbug" fear framing.
- ⚠️ **Retatrutide**: Company-reported, not peer-reviewed — label as Lilly-reported; separate weight-loss and A1c endpoints.
- ⚠️ **WHO Lancet Countdown**: Keep correlational framing; don't extrapolate beyond report's own indicators.
- ⚠️ **Miyoko's butter recall**: FDA.gov notice not directly retrieved — verify classification/lot codes before publishing.

---

## 9. Run Notes

- **Recurring themes flagged**: Ebola (3rd consecutive day — retained due to genuine new cross-border development); health-care-cost cluster (recurring, but rejected as existing with no new data).
- **Tool gaps**: Reddit, Exa semantic search, and direct social/X search were not independently queried this run — reliance was on injected SerpAPI Google News Radar + Google Trends prefetch, which fully covered this run's needs. No Trends data gap encountered.
- **Self-check**: `site_url` not configured — competitor-list fallback used qualitatively (no live scrape) to judge SERP saturation (e.g., GLP-1/weight-loss space judged highly saturated based on known competitor intensity in `configs/competitor_list.yaml`).
- **Source-link gaps**: Several headlines sourced from the Google Trends "Trending Now" block (Ebola/Nigeria, CDC superbugs, retatrutide) carry no `Link:` line in the prefetch data — all marked `[URL unverified]` per the no-fabrication rule rather than guessed. Recommend confirming primary URLs (cdc.gov, who.int, lilly.com, cnn.com) before final publication.
- Dashboard not generated as a live HTML file in this session — all required report sections delivered above per automation output-mode instructions.